ArticleTransboundary and emerging diseases2026
Molecular Prevalence and Genotype Detection of Babesia microti in Multiple Wild Rodent Species and Suncus murinus From Subtropical Mountainous Regions of South-Central Zhejiang, China.
Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Human babesiosis, an emerging zoonosis with ongoing geographic expansion, is primarily caused by Babesia microti, a tick-borne apicomplexan parasite that resides within host erythrocytes. While small mammals serve as its recognized reservoir hosts, the relative contribution of sympatric wild rodents and shrews in subtropical mountain endemic areas of Eastern China remains poorly characterized. In South-central Zhejiang, an endemic focus of human babesiosis, systematic data on local small-mammal hosts remain limited. In this study, 630 small mammals, comprising six rodent species and the shrew Suncus murinus, were captured across six counties in Zhejiang Province of China. Host identity was confirmed by morphological examination and mitochondrial cytochrome b (cytb) barcoding. Whole-blood DNA was screened for B. microti by TaqMan real-time quantitative PCR (qPCR); positive specimens were further analyzed by nested PCR (NPCR) targeting the 18S rRNA gene, followed by sequencing for genotype identification. The overall qPCR-positive rate was 3.0% (19/630). Geographically, B. microti infections were detected in four out of six surveyed counties, with Jinyun County showing the highest prevalence of 6.9%, followed by Qingyuan (4.0%), Wencheng (3.2%), and Qingtian (3.0%); no positive samples were identified in the Yunhe and Jingning counties. Among the sampled species, Niviventer lotipes showed the highest prevalence (11.7%, 12/103), followed by S. murinus (3.8%, 2/52), Alexandromys fortis (3.7%, 3/81), Apodemus agrarius (1.0%, 1/99), and Rattus norvegicus (0.5%, 1/222). No positive results were detected in R. tanezumi (n = 62) or Leopoldamys edwardsi (n = 11). Fifteen of the 19 samples yielded positive amplification by NPCR and were successfully sequenced. All 15 sequenced isolates were assigned to the Kobe genotype and exhibited close genetic relatedness to previously reported local human-derived and tick-derived strains. The dominance of a single haplotype (n = 14) across host species and counties indicates genetically homogeneous circulation of the Kobe genotype within local small-mammal communities, with host species rather than sampling county as the significant determinant of infection risk. These findings suggest that N. lotipes may be an important reservoir host in this region, and shrews may represent understudied secondary hosts, supporting the inclusion of both rodents and shrews in regional babesiosis surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.